{"id":7690,"date":"2022-06-14T14:23:32","date_gmt":"2022-06-14T14:23:32","guid":{"rendered":"https:\/\/r-biopharm.com\/?p=7690"},"modified":"2022-06-15T10:38:33","modified_gmt":"2022-06-15T10:38:33","slug":"r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia","status":"publish","type":"post","link":"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/","title":{"rendered":"R-Biopharm invierte en empresas emergentes de alta tecnolog\u00eda"},"content":{"rendered":"<div class=\"wpb-content-wrapper\">[vc_row][vc_column][vc_single_image image=\u00bb7626&#8243; img_size=\u00bbfull\u00bb alignment=\u00bbcenter\u00bb][mk_padding_divider size=\u00bb20&#8243;][vc_column_text css=\u00bb.vc_custom_1655289481125{margin-bottom: 0px !important;}\u00bb]High-Tech Gr\u00fcnderfonds hace m\u00e1s de 17 a\u00f1os que financia empresas tecnol\u00f3gicas emergentes en sus fases iniciales. Esta iniciativa ha presentado ahora su cuarto paquete de inversi\u00f3n junto con 40 empresas, y R-Biopharm es una de ellas. En la primera convocatoria, el paquete de inversi\u00f3n ha alcanzado ya un volumen comprometido de m\u00e1s de 400 millones de euros. La segunda convocatoria ser\u00e1 tambi\u00e9n en 2022.[\/vc_column_text][mk_padding_divider size=\u00bb20&#8243;][mk_image_slideshow images=\u00bb7659,7665,7602,7596,7590&#8243; image_height=\u00bb450&#8243; effect=\u00bbslide\u00bb][vc_column_text css=\u00bb.vc_custom_1655289493104{margin-bottom: 0px !important;}\u00bb]Impresiones de la primera convocatoria | \u00a9HTGF \u2013 Photos by Steffen Hauser[\/vc_column_text][mk_padding_divider size=\u00bb20&#8243;][vc_column_text css=\u00bb.vc_custom_1655289506391{margin-bottom: 0px !important;}\u00bb]Cada a\u00f1o, High-Tech Gr\u00fcnderfonds invierte en 40 empresas j\u00f3venes y prometedoras que desean desarrollar sus ideas en los campos de la tecnolog\u00eda digital, la tecnolog\u00eda industrial, las ciencias de la vida y los productos qu\u00edmicos. Con su participaci\u00f3n, R-Biopharm se complace en poder hacer otra importante contribuci\u00f3n a Alemania como pa\u00eds de negocios. Al fin y al cabo, la capacidad de iniciativa es con raz\u00f3n uno de los valores de la empresa. La inversi\u00f3n en Gr\u00fcnderfonds es otra faceta de la prospecci\u00f3n y promoci\u00f3n tecnol\u00f3gica que realiza R-Biopharm. Y por \u00faltimo, pero no menos importante, se trata de un paso m\u00e1s en el camino de la compa\u00f1\u00eda biotecnol\u00f3gica hacia productos y soluciones que van siempre m\u00e1s all\u00e1 de los desarrollos actuales.[\/vc_column_text][\/vc_column][\/vc_row]\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_single_image image=\u00bb7626&#8243; img_size=\u00bbfull\u00bb alignment=\u00bbcenter\u00bb][mk_padding_divider size=\u00bb20&#8243;][vc_column_text css=\u00bb.vc_custom_1655289481125{margin-bottom: 0px !important;}\u00bb]High-Tech Gr\u00fcnderfonds hace m\u00e1s de 17 a\u00f1os que financia empresas tecnol\u00f3gicas emergentes en sus fases iniciales. Esta iniciativa ha presentado ahora su cuarto paquete de inversi\u00f3n junto con 40 empresas, y R-Biopharm es una de ellas. En la primera convocatoria, el paquete de inversi\u00f3n ha alcanzado ya un [&hellip;]<\/p>\n","protected":false},"author":1114,"featured_media":7613,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[357],"tags":[],"class_list":["post-7690","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>R-Biopharm invierte en empresas emergentes de alta tecnolog\u00eda - R-Biopharm AG<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R-Biopharm invierte en empresas emergentes de alta tecnolog\u00eda - R-Biopharm AG\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][vc_single_image image=\u00bb7626&#8243; img_size=\u00bbfull\u00bb alignment=\u00bbcenter\u00bb][mk_padding_divider size=\u00bb20&#8243;][vc_column_text css=\u00bb.vc_custom_1655289481125{margin-bottom: 0px !important;}\u00bb]High-Tech Gr\u00fcnderfonds hace m\u00e1s de 17 a\u00f1os que financia empresas tecnol\u00f3gicas emergentes en sus fases iniciales. Esta iniciativa ha presentado ahora su cuarto paquete de inversi\u00f3n junto con 40 empresas, y R-Biopharm es una de ellas. En la primera convocatoria, el paquete de inversi\u00f3n ha alcanzado ya un [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/\" \/>\n<meta property=\"og:site_name\" content=\"R-Biopharm AG\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-14T14:23:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-15T10:38:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/r-biopharm.com\/wp-content\/uploads\/htgf_2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"niclas\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"niclas\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/\"},\"author\":{\"name\":\"niclas\",\"@id\":\"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4\"},\"headline\":\"R-Biopharm invierte en empresas emergentes de alta tecnolog\u00eda\",\"datePublished\":\"2022-06-14T14:23:32+00:00\",\"dateModified\":\"2022-06-15T10:38:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/\"},\"wordCount\":299,\"image\":{\"@id\":\"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/r-biopharm.com\/wp-content\/uploads\/htgf_2.png\",\"articleSection\":[\"Noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/\",\"url\":\"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/\",\"name\":\"R-Biopharm invierte en empresas emergentes de alta tecnolog\u00eda - R-Biopharm AG\",\"isPartOf\":{\"@id\":\"https:\/\/r-biopharm.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/r-biopharm.com\/wp-content\/uploads\/htgf_2.png\",\"datePublished\":\"2022-06-14T14:23:32+00:00\",\"dateModified\":\"2022-06-15T10:38:33+00:00\",\"author\":{\"@id\":\"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4\"},\"breadcrumb\":{\"@id\":\"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/#primaryimage\",\"url\":\"https:\/\/r-biopharm.com\/wp-content\/uploads\/htgf_2.png\",\"contentUrl\":\"https:\/\/r-biopharm.com\/wp-content\/uploads\/htgf_2.png\",\"width\":800,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/r-biopharm.com\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"R-Biopharm invierte en empresas emergentes de alta tecnolog\u00eda\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/r-biopharm.com\/#website\",\"url\":\"https:\/\/r-biopharm.com\/\",\"name\":\"R-Biopharm AG\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/r-biopharm.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4\",\"name\":\"niclas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/r-biopharm.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g\",\"caption\":\"niclas\"},\"url\":\"https:\/\/r-biopharm.com\/es\/author\/niclas\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"R-Biopharm invierte en empresas emergentes de alta tecnolog\u00eda - R-Biopharm AG","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/","og_locale":"es_ES","og_type":"article","og_title":"R-Biopharm invierte en empresas emergentes de alta tecnolog\u00eda - R-Biopharm AG","og_description":"[vc_row][vc_column][vc_single_image image=\u00bb7626&#8243; img_size=\u00bbfull\u00bb alignment=\u00bbcenter\u00bb][mk_padding_divider size=\u00bb20&#8243;][vc_column_text css=\u00bb.vc_custom_1655289481125{margin-bottom: 0px !important;}\u00bb]High-Tech Gr\u00fcnderfonds hace m\u00e1s de 17 a\u00f1os que financia empresas tecnol\u00f3gicas emergentes en sus fases iniciales. Esta iniciativa ha presentado ahora su cuarto paquete de inversi\u00f3n junto con 40 empresas, y R-Biopharm es una de ellas. En la primera convocatoria, el paquete de inversi\u00f3n ha alcanzado ya un [&hellip;]","og_url":"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/","og_site_name":"R-Biopharm AG","article_published_time":"2022-06-14T14:23:32+00:00","article_modified_time":"2022-06-15T10:38:33+00:00","og_image":[{"width":800,"height":800,"url":"https:\/\/r-biopharm.com\/wp-content\/uploads\/htgf_2.png","type":"image\/png"}],"author":"niclas","twitter_misc":{"Escrito por":"niclas","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/#article","isPartOf":{"@id":"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/"},"author":{"name":"niclas","@id":"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4"},"headline":"R-Biopharm invierte en empresas emergentes de alta tecnolog\u00eda","datePublished":"2022-06-14T14:23:32+00:00","dateModified":"2022-06-15T10:38:33+00:00","mainEntityOfPage":{"@id":"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/"},"wordCount":299,"image":{"@id":"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/#primaryimage"},"thumbnailUrl":"https:\/\/r-biopharm.com\/wp-content\/uploads\/htgf_2.png","articleSection":["Noticias"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/","url":"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/","name":"R-Biopharm invierte en empresas emergentes de alta tecnolog\u00eda - R-Biopharm AG","isPartOf":{"@id":"https:\/\/r-biopharm.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/#primaryimage"},"image":{"@id":"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/#primaryimage"},"thumbnailUrl":"https:\/\/r-biopharm.com\/wp-content\/uploads\/htgf_2.png","datePublished":"2022-06-14T14:23:32+00:00","dateModified":"2022-06-15T10:38:33+00:00","author":{"@id":"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4"},"breadcrumb":{"@id":"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/#primaryimage","url":"https:\/\/r-biopharm.com\/wp-content\/uploads\/htgf_2.png","contentUrl":"https:\/\/r-biopharm.com\/wp-content\/uploads\/htgf_2.png","width":800,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/r-biopharm.com\/es\/r-biopharm-invierte-en-empresas-emergentes-de-alta-tecnologia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/r-biopharm.com\/es\/"},{"@type":"ListItem","position":2,"name":"R-Biopharm invierte en empresas emergentes de alta tecnolog\u00eda"}]},{"@type":"WebSite","@id":"https:\/\/r-biopharm.com\/#website","url":"https:\/\/r-biopharm.com\/","name":"R-Biopharm AG","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/r-biopharm.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4","name":"niclas","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/r-biopharm.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g","caption":"niclas"},"url":"https:\/\/r-biopharm.com\/es\/author\/niclas\/"}]}},"_links":{"self":[{"href":"https:\/\/r-biopharm.com\/es\/wp-json\/wp\/v2\/posts\/7690","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/r-biopharm.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/r-biopharm.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/r-biopharm.com\/es\/wp-json\/wp\/v2\/users\/1114"}],"replies":[{"embeddable":true,"href":"https:\/\/r-biopharm.com\/es\/wp-json\/wp\/v2\/comments?post=7690"}],"version-history":[{"count":1,"href":"https:\/\/r-biopharm.com\/es\/wp-json\/wp\/v2\/posts\/7690\/revisions"}],"predecessor-version":[{"id":7691,"href":"https:\/\/r-biopharm.com\/es\/wp-json\/wp\/v2\/posts\/7690\/revisions\/7691"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/r-biopharm.com\/es\/wp-json\/wp\/v2\/media\/7613"}],"wp:attachment":[{"href":"https:\/\/r-biopharm.com\/es\/wp-json\/wp\/v2\/media?parent=7690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/r-biopharm.com\/es\/wp-json\/wp\/v2\/categories?post=7690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/r-biopharm.com\/es\/wp-json\/wp\/v2\/tags?post=7690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}